ArticleCancer biology & therapy2015

Therapeutic approach guided by genetic alteration: use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression.

Jacob S Lipkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.